The Wisconsin Economic Development Corporation (WEDC) announced today that it will provide tax credits of up to $9 million to Exact Sciences Corp. (NASDAQ: EXAS) as part of the cancer diagnostics company’s ongoing growth in the state.
Madison is in a sweet spot when it comes to creating health care IT software, programs and applications, thanks in large part to the success of Epic Systems, the electronic medical records giant located in nearby Verona. So says Mark Bakken, founder of HealthX Ventures and the former head of Nordic Consulting Partners.
Cellular Dynamics International, Inc. announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA “superdonors.”
Conroy is being recognized for leading Exact Sciences to being a significant force in the national fight against cancer.
Exact Sciences Corp. and Mayo Clinic today announced a five-year extension and expansion of their collaboration, broadening their efforts to develop screening, surveillance and diagnostic tests beyond colorectal cancer to address other diseases within the gastrointestinal tract.
A lot of times, when we think about tech businesses, we think about California and the Silicon Valley. But over the years, Madison has become a Midwestern hot spot for up-and-coming tech start ups.
The Madison Startup Fair on University of Wisconsin-Madison’s campus brings together a cross-section of local startups each year, from software to 3D printing technology to alternative insulation material for outdoor gear.
With its home test kit for colorectal cancer now available for use in the U.S. and Europe, Exact Sciences Corp. has become one of the fastest-growing businesses in the Madison area.
14 major Wisconsin companies will engage in a series of 15-minute meetings with emerging companies from across the state which apply for the chance to pitch their products, services and ideas at the Wisconsin Tech Summit.
Invenra has raised just over $2 million from investors that it will use to further develop its cell-free protein expression technology, a new SEC filing shows.